A growing body of research indicates that popular weight-loss drugs, such as Ozempic and Wegovy, may have additional benefits. These medications might help treat or even prevent certain types of cancer. This is an unexpected advantage linked with GLP-1s, a class of drugs now used by one-in-eight adults in the United States.
William Brangham reports on this new finding as part of his coverage for PBS News. Brangham is known for his work as an award-winning correspondent, producer, and substitute anchor for PBS News Hour. He also hosts the show Horizons from PBS.
Cancer Death Rates Drop: Challenges in Addressing Disparities 
A Study on COVID-19 Vaccine Effectiveness Published 
Efforts to Combat Hospice Fraud and Protect Patient Care 
Study on Vaccine’s Impact on Emergency Visits and Hospitalizations 
Protein Tubulin Offers Hope in Combatting Alzheimer’s and Parkinson’s Disease 
Medicare Initiative Set to Lower Cost of Popular Weight-Loss Medications